Georgia vs United Arab Emirates: Percentage of bloodstream infection due to Escherichia coli resistant
Georgia
46.5%
in 2022
United Arab Emirates
52.4%
in 2022
Georgia rank
20th
United Arab Emirates rank
19th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Georgia
- United Arab Emirates
How they compare
United Arab Emirates currently reports 52.4% against 46.5% in Georgia, a difference of 5.9%.
That makes United Arab Emirates's figure about 1.1 times Georgia's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was United Arab Emirates ahead.
Georgia ranks 20th and United Arab Emirates ranks 19th of 50 countries.
Across the 2 decades both report, Georgia averaged higher in 1 and United Arab Emirates in 1.
Head to head by decade
| Decade | Georgia | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.1% | 47.5% | 5.6% | Georgia |
| 2020s | 41.8% | 52.7% | 10.9% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Georgia or United Arab Emirates?
- United Arab Emirates, at 52.4% against 46.5% in Georgia as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Georgia and United Arab Emirates?
- 5.9%, with United Arab Emirates ahead.
- How many years of comparable data are there for Georgia and United Arab Emirates?
- 6 years are reported by both, from 2017 to 2022.
- How do Georgia and United Arab Emirates rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Georgia ranks 20th and United Arab Emirates ranks 19th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.